1. Home
  2. RNA vs RFAM Comparison

RNA vs RFAM Comparison

Compare RNA & RFAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

SELL

Current Price

$6.45

Market Cap

141.3M

Sector

Health Care

ML Signal

SELL

RFAM

RF Acquisition Corp III Ordinary Shares

SELL

Current Price

$10.03

Market Cap

139.5M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
RNA
RFAM
Founded
2025
2025
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.3M
139.5M
IPO Year
2025
2025

Fundamental Metrics

Financial Performance
Metric
RNA
RFAM
Price
$6.45
$10.03
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $22.00
N/A
AVG Volume (30 Days)
★ 205.6K
7.7K
Earning Date
11-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$104.53
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.47
$9.77
52 Week High
$73.06
$10.02

Technical Indicators

Market Signals
Indicator
RNA
RFAM
Relative Strength Index (RSI) 24.72 73.13
Support Level N/A $9.77
Resistance Level $8.50 N/A
Average True Range (ATR) 0.42 0.00
MACD -0.09 0.00
Stochastic Oscillator 1.49 100.00

Price Performance

Historical Comparison
RNA
RFAM

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

About RFAM RF Acquisition Corp III Ordinary Shares

RF Acquisition Corp III is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination.

Share on Social Networks: